MAZE

Maze Therapeutics, Inc. Common Stock

27.86

USD

-0.52

-1.85%

Sep 23, 12:42 UTC -4

Open

Maze Therapeutics, Inc. Common Stock Profile

About

Maze Therapeutics Inc. is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases. Maze Therapeutics Inc. is based in SOUTH SAN FRANCISCO, Calif.

Info & Links

CEO

Jason Coloma

Headquarters

171 OYSTER POINT BOULEVARD, SUITE 300
SAN FRANCISCO, CA 94080, UNITED STATES

Auditor

Ernst & Young LLP

Share holders

Employees

141

Maze Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

1.55B

Enterprise Value

1.38B

Enterprise Value/EBITDA(ttm)

-9.66

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

2.73

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

25.00%

Operating Margin(ttm)

Profit Margin(ttm)

-30.26%

Return on Equity(ttm)

-34.94%

Return on Invested Capital(ttm)

-33.12%

Return on Assets(ttm)

-30.18%

Income Statement

Revenue(ttm)

20.00M

Revenue Per Share(ttm)

0.36

Gross Profit(ttm)

20.00M

EBITDA(ttm)³

-143.21M

Net Income Available to Common(ttm)

-133.59M

Diluted EPS(ttm)

-2.52

Share Statistics

Beta (5Y Monthly)

2.17

52-Week Change

17.68%

S&P 500 52-Week Change

17.10%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

55.55M

Dividend Yield

0.00%

Float⁴

52.60M

% Held by Insiders

5.30%

% Held by Institutions

Balance Sheet

Total Cash(mrq)

411.09M

Total Cash Per Share(mrq)

7.40

Total Debt(mrq)

38.96M

Total Debt/Equity(mrq)

8.60%

Current Ratio(mrq)

18.31%

Quick Ratio(mrq)

18.31%

Book Value Per Share(mrq)

8.16

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.92

Free Cash Flow(ytd)

-54.37M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.